PEPTONIC medical AB (28L) Income Statement

0 Followers

PEPTONIC medical AB Income Statement

Last quarter (Q2 2022), PEPTONIC medical AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, PEPTONIC medical AB's net income was $-9.04M. See PEPTONIC medical AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 19.07M	$ 13.09M	$ 2.56M	$ 232.31K	$ 75.67K
Operating Expenses	$ ―	$ ―	$ ―	$ ―	$ ―
Depreciation and Amortization	$ 27.05M	$ 3.29M	$ 2.86M	$ 75.67K	$ 85.99K
EBITDA	$ -46.56M	$ -27.77M	$ -21.02M	$ -14.29M	$ -12.84M
Operating Income	$ -73.72M	$ -31.05M	$ -23.92M	$ -14.38M	$ -12.96M
Other Income/Expenses	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income	$ -73.69M	$ -31.09M	$ -24.51M	$ -14.94M	$ -12.97M
Per Share Metrics
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Weighted Average Shares Outstanding	―	―	―	―	―
Weighted Average Shares Outstanding (Diluted)	―	―	―	―	―

PEPTONIC medical AB (28L) Income Statement

PEPTONIC medical AB Income Statement

PEPTONIC medical AB Earnings and Revenue History